Table 3 Survival outcome of study patients in correlation to their demographic and clinical characteristics
From: Management and outcome of pediatric metastatic Wilms’ tumor at the National Cancer Institute, Egypt
Factors | N | 3-year EFS | 3-year OS | |||
|---|---|---|---|---|---|---|
% | P value | % | P value | |||
All | 24 | 48.2 | 53.8 | |||
Age | < 5 years | 15 | 60.0 | 0.065 | 57.1 | 0.633 |
≥ 5 years | 9 | 25.9 | 50.8 | |||
Gender | Male | 7 | 53.6 | 0.827 | 47.6 | 0.705 |
Female | 17 | 37.6 | 56.5 | |||
Initial management | Biopsy/CTH | 15 | 37.9 | 0.464 | 66.2 | 0.137 |
Nephrectomy | 9 | 44.4 | 44.4 | |||
Initial metastases | Lung | 21 | 47.5 | 57.6 | ||
Lung and liver | 3 | 0 | * | 33.3 | * | |
IVC involvement | Yes | 3 | 33.3 | 66.7 | ||
No | 21 | 45.5 | * | 51.3 | * | |
Path. LNs involvement | Yes | 6 | 50.0 | 33.3 | ||
No | 9 | 19.5 | 0.657 | 34.6 | 0.655 | |
Pulmonary response at W6 | RCR | 7 | 68.6 | 85.7 | ||
SIR | 14 | 39.0 | 0.143 | 41.3 | 0.067 | |
SRI | ≤ 14 days | 7 | 71.4 | 64.3 | ||
> 14 days | 14 | 34.7 | 0.240 | 48.8 | 0.411 | |